Phase 1 data suggest that WVE-007, an investigational siRNA drug given by injection, leads to reductions in visceral fat, waist circumference, and body weight.

This year’s RSAC delivered on its anticipated emphasis on AI but with some surprises as to how CISOs should rethink ...

Hoffenheim were in desperate need of a spark when they were hovering above the relegation zone in late 2024. In former ...

A ₹1,000 crore market is set to grow 5x to ₹5,000 crore by 2030 as prices drop 40–50% post patent expiry. Three early movers ...

NASA is poised to launch four astronauts April 1 on a historic nine-day trip around the moon and back. Here's everything to ...

LEO Pharma A/S, a global leader in medical dermatology, today announced the presentation of new post-hoc analyses of 12‑month real‑world data from the TRACE study of tralokinumab, at the 2026 American ...

Viridian Therapeutics (NASDAQ:VRDN) reported top-line results from its REVEAL-1 Phase III clinical trial evaluating ...

The path traversal flaw, allowing access to arbitrary files, adds to a growing set of input validation issues in AI pipelines.

Major investment, accompanied by new long-term commercial agreements, in Cambridge Mobile Telematics designed to expand global road safety platform and real-time AI risk models.

Studies highlight reduced total cost of care and select healthcare resource utilization outcomes in total knee arthroplasty (TKA) and spinal fusion -- BRISBANE, Calif., March 30, 2026 (GLOBE NEWSWIRE) ...

The government is set to begin a nationwide rollout of a long-acting HIV prevention injection, Cabotegravir (CAB-LA), this week, following a successful one-year pilot phase. The rollout aims to ...